SUMMARY Extraintestinal pathogenic Escherichia coli (ExPEC) strains are responsible for a
majority of human extraintestinal infections globally, resulting in enormous direct medical …

In 2008, a previously unknown Escherichia coli clonal group, sequence type 131 (ST131),
was identified on three continents. Today, ST131 is the predominant E. coli lineage among …

The possible zoonotic spread of antimicrobial-resistant bacteria is controversial. This review
discusses global molecular epidemiological data combining both analyses of the …

Pathogenic Escherichia coli strains cause a wide variety of intestinal and extraintestinal
infections. The widespread geographical clonal dissemination of intestinal pathogenic E …

Escherichia coli has a rich history as biology's 'rock star', driving advances across many
fields. In the wild, E. coli resides innocuously in the gut of humans and animals but is also a …

Escherichia coli is one of the most well-adapted and pathogenically versatile bacterial
organisms. It causes a variety of human infections, including gastrointestinal illnesses and …

Escherichia coli (E. coli) exhibits considerable physiological and metabolic versatility and
includes a variety of non-pathogenic, commensal variants, which belong to the normal gut …

Escherichia coli sequence type 131 (ST131) is an extensively antimicrobial-resistant E. coli
clonal group that has spread explosively throughout the world. Recent molecular …

Uropathogenic Escherichia coli (UPEC) is the most common cause of community-and
hospital-acquired urinary tract infections (UTIs). Isolates from uncomplicated community …

Background. Escherichia coli sequence type 131 (ST131), typically fluoroquinolone-
resistant (FQ-R) and/or extended-spectrum β-lactamase (ESBL)–producing, has emerged …